221 related articles for article (PubMed ID: 32062679)
41. Can we define excess vaginal space? - Genital hiatus size and prolapse severity are correlated with cube pessary size.
Nemeth Z; Farkas N; Farkas B
Eur J Obstet Gynecol Reprod Biol; 2020 Oct; 253():61-64. PubMed ID: 32791394
[TBL] [Abstract][Full Text] [Related]
42. Parameters associated with unsuccessful pessary fitting for pelvic organ prolapse up to three months follow-up: a systematic review and meta-analysis.
Manzini C; Morsinkhof LM; van der Vaart CH; Withagen MIJ; Grob ATM
Int Urogynecol J; 2022 Jul; 33(7):1719-1763. PubMed ID: 35037973
[TBL] [Abstract][Full Text] [Related]
43. Adverse events associated with pessary use over one year among women attending a pessary care clinic.
Kakkar A; Reuveni-Salzman A; Bentaleb J; Belzile E; Merovitz L; Larouche M
Int Urogynecol J; 2023 Aug; 34(8):1765-1770. PubMed ID: 36715742
[TBL] [Abstract][Full Text] [Related]
44. Factors Affecting Successfulness of Vaginal Pessary Use for the Treatment of Pelvic Organ Prolapse.
Lekskulchai O; Wanichsetakul P
J Med Assoc Thai; 2015 Apr; 98 Suppl 3():S115-20. PubMed ID: 26387398
[TBL] [Abstract][Full Text] [Related]
45. Adherence to support pessary in the treatment of pelvic organ prolapse: a retrospective study conducted among 1,371 women.
Brandt CH; Yamolaei M; Wu C; Hansen UD; Rasch V
Int Urogynecol J; 2024 Jan; 35(1):69-75. PubMed ID: 37548745
[TBL] [Abstract][Full Text] [Related]
46. Pessaries for pelvic organ prolapse: evaluation of vaginal discharge and pain during pessary cleaning in an outpatient setting.
Kruyt LM; van der Ploeg JM; Lammers K; van Etten-Debruijn BA; Niemeijer AS; Hakvoort RA
Int Urogynecol J; 2024 Feb; 35(2):333-339. PubMed ID: 37796331
[TBL] [Abstract][Full Text] [Related]
47. A prospective study of pessary use for severe pelvic organ prolapse: 3-year follow-up outcomes.
Li B; Chen Q; Zhang J; Yu C; Zhang L; Chen L
Arch Gynecol Obstet; 2020 May; 301(5):1213-1218. PubMed ID: 32274637
[TBL] [Abstract][Full Text] [Related]
48. What Are the Clinical Factors That Are Predictive of Persistent Pessary Use at 12 Months?
Chan MC; Hyakutake M; Yaskina M; Schulz JA
J Obstet Gynaecol Can; 2019 Sep; 41(9):1276-1281. PubMed ID: 30712905
[TBL] [Abstract][Full Text] [Related]
49. Ratio of Women with POP Using Pessary, Improvement in Urination and Quality of Life.
Gómez de Quero Córdoba M; Pérez JPH; Merino ÁV; Zaldibar CR; López MR; Bernal PP
Arch Esp Urol; 2022 Jun; 75(5):441-446. PubMed ID: 35983816
[TBL] [Abstract][Full Text] [Related]
50. Feasibility of using pessaries for treatment of pelvic organ prolapse in rural Nepal.
Robert M; Govan AJ; Lohani U; Uprety A
Int J Gynaecol Obstet; 2017 Mar; 136(3):325-330. PubMed ID: 28099682
[TBL] [Abstract][Full Text] [Related]
51. Predictors for dislodgment of vaginal pessary within one year in women with pelvic organ prolapse.
Cheung RYK; Lee LLL; Chung TKH; Chan SSC
Maturitas; 2018 Feb; 108():53-57. PubMed ID: 29290215
[TBL] [Abstract][Full Text] [Related]
52. Patient Satisfaction and Symptoms Improvement in Women Using a Vginal Pessary for The Treatment of Pelvic Organ Prolapse.
Radnia N; Hajhashemi M; Eftekhar T; Deldar M; Mohajeri T; Sohbati S; Ghanbari Z
J Med Life; 2019; 12(3):271-275. PubMed ID: 31666830
[TBL] [Abstract][Full Text] [Related]
53. Vaginal pessaries in the management of symptomatic pelvic organ prolapse in rural Kilimanjaro, Tanzania: a pre-post interventional study.
Shayo BC; Masenga GG; Rasch V
Int Urogynecol J; 2019 Aug; 30(8):1313-1321. PubMed ID: 30121703
[TBL] [Abstract][Full Text] [Related]
54. Quality of life and vaginal symptoms of postmenopausal women using pessary for pelvic organ prolapse: a prospective study.
Coelho SCA; Marangoni-Junior M; Brito LGO; Castro EB; Juliato CRT
Rev Assoc Med Bras (1992); 2018 Dec; 64(12):1103-1107. PubMed ID: 30569986
[TBL] [Abstract][Full Text] [Related]
55. The cube pessary: an underestimated treatment option for pelvic organ prolapse? Subjective 1-year outcomes.
Nemeth Z; Nagy S; Ott J
Int Urogynecol J; 2013 Oct; 24(10):1695-701. PubMed ID: 23579291
[TBL] [Abstract][Full Text] [Related]
56. Risk Factors for Dislodgment of Vaginal Pessaries in Women With Pelvic Organ Prolapse: A Cohort Study.
Coelho SCA; Giraldo PC; de Castro EB; Brito LGO; Juliato CRT
Female Pelvic Med Reconstr Surg; 2021 Jan; 27(1):e247-e251. PubMed ID: 32487886
[TBL] [Abstract][Full Text] [Related]
57. Vaginal Pessary in Women With Symptomatic Pelvic Organ Prolapse: A Randomized Controlled Trial.
Cheung RY; Lee JH; Lee LL; Chung TK; Chan SS
Obstet Gynecol; 2016 Jul; 128(1):73-80. PubMed ID: 27275798
[TBL] [Abstract][Full Text] [Related]
58. Predictors of unsuccessful pessary fitting in women with prolapse: a cross-sectional study in general practice.
Panman CM; Wiegersma M; Kollen BJ; Burger H; Berger MY; Dekker JH
Int Urogynecol J; 2017 Feb; 28(2):307-313. PubMed ID: 27525693
[TBL] [Abstract][Full Text] [Related]
59. Timing of Office-Based Pessary Care: A Randomized Controlled Trial.
Propst K; Mellen C; O'Sullivan DM; Tulikangas PK
Obstet Gynecol; 2020 Jan; 135(1):100-105. PubMed ID: 31809432
[TBL] [Abstract][Full Text] [Related]
60. A 5-year prospective study of vaginal pessary use for pelvic organ prolapse.
Lone F; Thakar R; Sultan AH; Karamalis G
Int J Gynaecol Obstet; 2011 Jul; 114(1):56-9. PubMed ID: 21575953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
